Literature DB >> 109097

Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission.

A C Steere, J A Hardin, S Ruddy, J G Mummaw, S E Malawista.   

Abstract

Forty-eight patients with erythema chronicum migrans (ECM) were studied prospectively for 6 to 18 months. Twenty-six patients had no later symptoms, but 22 subsequently developed Lyme arthritis and 9 of them also experienced neurologic abnormalities. Eighty-seven percent of patients with active ECM followed by subsequent involvement had cryoglobulins containing IgM compared to only 13% of those with active ECM and no later symptoms. The former group also had significantly lower IgG, C3 and C4 levels. Sixty-seven percent of patients still had serum cryoglobulins when neurologic disease was most active, and 45% had them when joint symptoms were most severe, but only 11% continued to have small amounts in remission. The number of patients who continued to have serum cryoglobulins with recurrent attacks of arthritis decreased with time. In contrast, patients always had cryoglobulins in joint fluid, a finding Lyme arthritis shares with rheumatoid arthritis. The cryoprecipitates from 2 of 10 patients contained particles with internal structure, but their viral nature is problematic. All components of antisera obtained from goats and rabbits immunized with cryoglobulins were absorbed by normal human sera. The amount of IgM in cryoglobulins correlated directly with serum IgM, which generally rose during exacerbations and fell during remissions; serum IgG and IgA moved conversely. Thus, IgM was an important correlate of clinical disease activity and IgG or remission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109097     DOI: 10.1002/art.1780220506

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  24 in total

1.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

Review 2.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

Review 3.  Pathogenesis of Lyme disease.

Authors:  S E Malawista
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 4.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

5.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

6.  Lyme disease in northern California.

Authors:  J Campagna; P E Lavoie; N S Birnbaum; D P Furman
Journal:  West J Med       Date:  1983-09

7.  Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete.

Authors:  A G Barbour; W Burgdorfer; E Grunwaldt; A C Steere
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

8.  Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Authors:  J E Craft; D K Fischer; G T Shimamoto; A C Steere
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.

Authors:  P Cacoub; N Boukli; P Hausfater; A Garbarg-Chenon; P Ghillani; V Thibault; L Musset; J M Huraux; J C Piette
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

10.  Comparison of polymerase chain reaction with culture and serology for diagnosis of murine experimental Lyme borreliosis.

Authors:  A R Pachner; N Ricalton; E Delaney
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.